Whitehawk Therapeutics (WHWK) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Whitehawk Therapeutics (WHWK) over the last 5 years, with Sep 2025 value amounting to -$0.26.
- Whitehawk Therapeutics' EPS (Weighted Average and Diluted) rose 43.48% to -$0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.13, marking a year-over-year increase of 105.70%. This contributed to the annual value of -$2.36 for FY2024, which is 3.28% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) is -$0.26, which was up 65.79% from -$0.76 recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $6.96 in Q4 2021 and a low of -$9.17 during Q3 2021.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.60 (2023), whereas its average is -$0.36.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 13,261.66% in 2021, then skyrocketed by 369.12% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at $6.96 in 2021, then plummeted by 106.90% to -$0.48 in 2022, then decreased by 25.00% to -$0.60 in 2023, then fell by 13.33% to -$0.68 in 2024, then spiked by 43.48% to -$0.26 in 2025.
- Its last three reported values are -$0.26 in Q3 2025, -$0.76 for Q2 2025, and $1.83 during Q1 2025.